News
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price ...
Annual Shareholders Meeting was a governance-heavy affair, with proposals flying faster than a biotech merger rumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback